Immunosuppression in murine malaria. I. General characteristics.
D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D001769:Blood / Q000382:microbiology; D003877:Dermatitis, Contact / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection; D006433:Hemocyanins; D006462:Hemolytic Plaque Technique; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007114:Immunization; D007165:Immunosuppression Therapy; D037102:Lectins; D008264:Macrophages; D008288:Malaria / Q000276:immunology*; D051379:Mice; D010961:Plasmodium / Q000302:isolation & purification; D011830:Radiation Effects; D012756:Sheep; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology / Q000637:transplantation; D014184:Transplantation, Homologous; D005719:gamma-Globulins
D037102:Lectins; D005719:gamma-Globulins; D006433:Hemocyanins